Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Maynard

Showing results (151-160 of 448) with videos related to

Pageof 45
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The costs of managing severe cancer pain and potential savings from transdermal administrationK Bloor, B Leese, A Maynard
Biochemistry|November 11, 2009
Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7Jamie N Sutherland, Jennifer A Maynard
Current Opinion in Chemical Engineering|June 19, 2018
Engineering therapeutic antibodies to combat infectious diseasesEllen K Wagner, Jennifer A Maynard
The New England Journal of Medicine|July 3, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsMichelle A Maynard, Stephen A Huang
Pharmacoeconomics|April 8, 1992
A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countriesB Leese, J Hutton, A Maynard
British Journal of Addiction|June 1, 1987
Data Note--9. Measuring the social costs of addictive substancesA Maynard, G Hardman, A Whelan
Health and Social Service Journal|September 30, 1985
Geriatric day hospitals on trialC Donaldson, K Wright, A Maynard
BMJ (Clinical Research Ed.)|July 6, 1996
Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industryK Bloor, A Maynard, N Freemantle
BMJ (Clinical Research Ed.)|May 12, 2001
New Zealand's new health sector reforms: back to the future?N Devlin, A Maynard, N Mays
The Health Service Journal|August 19, 1990
Grasping the nettleR Douglas, R Flux, A Maynard
Pageof 45

Showing results (151-160 of 448) with videos related to

Sort By:
Pageof 45
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
The costs of managing severe cancer pain and potential savings from transdermal administrationK Bloor, B Leese, A Maynard
Biochemistry|November 11, 2009
Characterization of a key neutralizing epitope on pertussis toxin recognized by monoclonal antibody 1B7Jamie N Sutherland, Jennifer A Maynard
Current Opinion in Chemical Engineering|June 19, 2018
Engineering therapeutic antibodies to combat infectious diseasesEllen K Wagner, Jennifer A Maynard
The New England Journal of Medicine|July 3, 2014
Thyroid hormone inactivation in gastrointestinal stromal tumorsMichelle A Maynard, Stephen A Huang
Pharmacoeconomics|April 8, 1992
A comparison of the costs and benefits of recombinant human erythropoietin (epoetin) in the treatment of chronic renal failure in 5 European countriesB Leese, J Hutton, A Maynard
British Journal of Addiction|June 1, 1987
Data Note--9. Measuring the social costs of addictive substancesA Maynard, G Hardman, A Whelan
Health and Social Service Journal|September 30, 1985
Geriatric day hospitals on trialC Donaldson, K Wright, A Maynard
BMJ (Clinical Research Ed.)|July 6, 1996
Lessons from international experience in controlling pharmaceutical expenditure. III: Regulating industryK Bloor, A Maynard, N Freemantle
BMJ (Clinical Research Ed.)|May 12, 2001
New Zealand's new health sector reforms: back to the future?N Devlin, A Maynard, N Mays
The Health Service Journal|August 19, 1990
Grasping the nettleR Douglas, R Flux, A Maynard
Pageof 45